Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Share
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Coronavirus has caused an unprecedented surge in the demand for contactless payment, but the U.S. is unlikely to stop using cash anytime soon. 14:13 Wed, Dec 2 20202:53 PM EST
CNBC’s Eamon Javers joins ‘Power Lunch’ to discuss the SEC and X investigating a fake SEC post.
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Catherine Seifert of CFRA discusses the likelihood of Berkshire Hathaway pivoting to ‘Green New Deal’ investments under a Biden presidency. 02:02 Sun, Nov 8 202010:50 PM EST
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Dave Sekera, chief U.S market strategist for Morningstar, joined CNBC’s Julianna Tatelbaum on Wednesday for a frank conversation on the market outlook. 33:50 Wed, Jul 13 20229:16 AM EDT
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Beer is the most popular alcoholic drink in the U.S. But did you know the beer industry employs over 2 million Americans? 00:53 Tue, Apr 7 20154:00 PM EDT
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Detlev Von Platen, Porsche Cars North America talks to CNBC’s Phil LeBeau about the luxury automaker’s newest sports model. 02:17 Mon, Jan 11 20166:30 AM EST